Kristin I Stanford

Title: Kristin I Stanford: Innovator in Metabolic Disorder Treatments

Introduction

Kristin I Stanford is a prominent inventor based in Roslindale, MA (US). She has made significant contributions to the field of metabolic disorders through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing methods and compositions that address critical health issues such as diabetes and obesity.

Latest Patents

One of her latest patents is titled "Methods and compositions relating to lipokines for treating metabolic disorders." This invention includes methods and compositions for treating metabolic disorders, including metabolic syndrome and hyperlipidemia, as well as associated conditions like obesity and diabetes. The method involves administering 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) to human subjects. Additionally, it encompasses methods and compositions aimed at enhancing skeletal muscle fatty acid uptake and oxidation, increasing mitochondrial respiration in skeletal muscle, and improving exercise capacity.

Another significant patent is "Exercise-regulated adipokines as therapy for diabetes management." This invention relates to methods and compositions that effectively regulate glycemic control in individuals who are diabetic or prediabetic. The invention provides therapeutically effective amounts of identified secreted proteins to modulate glycemic control, thereby treating or preventing diabetes in these subjects.

Career Highlights

Kristin I Stanford is affiliated with the Joslin Diabetes Center, Inc., where she continues her research and development efforts. Her work has garnered attention for its potential impact on diabetes management and metabolic health.

Collaborations

One of her notable collaborators is Laurie J Goodyear, who is also a respected figure in the field of diabetes research. Their partnership highlights the importance of collaboration in advancing scientific knowledge and developing effective treatments.

Conclusion

Kristin I Stanford's innovative contributions to the treatment of metabolic disorders underscore her role as a leading inventor in the field. Her patents reflect a commitment to improving health outcomes for individuals affected by diabetes and related conditions.